In The News

This page contains articles written by persons not affiliated with vTv Therapeutics. The views expressed in the articles are those of the author and do not reflect the views of the company. vTv Therapeutics disavows any obligation to update or correct the information contained in these articles.

VTV Celebrates a Double Positive

Yesterday’s clinical study success has underlined VTV’s status as a small-cap bet on Alzheibetes.
Read More

Vtv scores phase II TD in T1D as Alzheimer’s bid RAGEs against dying of light

Read More